Does Sanders have the votes to subpoena a Novo exec?

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

The pharma CEO behind $35 insulin

As I was reporting out a story about insulin pricing, a source asked me a question that stopped me in my tracks: Where did the ubiquitous $35 per month figure come from?

Both President Biden and former President Trump have been eager to claim credit for $35 insulin. The number was included in the Inflation Reduction Act’s Medicare insulin protections, has popped up in states, has been the basis of bills in Congress, and has become the go-to standard for companies’ patient assistance.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In